A new meta-analysis, published in Frontiers in Cardiovascular Medicine, focused on data from nearly 3,000 patients with severe symptomatic aortic stenosis.

The 88-year-old patient was originally not seen as a viable candidate for TAVR or surgery.

While cardiac damage reverses in many patients following treatment, it can actually continue to get worse in others. 

A group of renowned TAVR specialists examined data from 783 pairs of intermediate-risk patients, sharing their findings in the Journal of the American College of Cardiology.

Researchers think this new technique could be beneficial for patients presenting with both severe symptomatic aortic stenosis and chronic kidney disease. 

When patients wear VR glasses during transcatheter aortic valve replacement, they say it helps time go by more quickly and reduces anxiety.

A new retrospective study from the Mayo Clinic focused on patients with no other need for anticoagulation.